Cargando…

Expanded autologous regulatory T-lymphocyte infusions in ALS: A phase I, first-in-human study

OBJECTIVE: To determine whether autologous infusions of expanded regulatory T lymphoctyes (Tregs) into patients with amyotrophic lateral sclerosis (ALS) are safe and tolerable during early and later stages of disease. METHODS: Three patients with ALS, with no family history of ALS, were selected bas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thonhoff, Jason R., Beers, David R., Zhao, Weihua, Pleitez, Milvia, Simpson, Ericka P., Berry, James D., Cudkowicz, Merit E., Appel, Stanley H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961523/ https://www.ncbi.nlm.nih.gov/pubmed/29845093 http://dx.doi.org/10.1212/NXI.0000000000000465

Ejemplares similares

Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis
por: Thonhoff, Jason R., et al.
Publicado: (2022)

Extracellular Vesicles Derived From Ex Vivo Expanded Regulatory T Cells Modulate In Vitro and In Vivo Inflammation
por: Thome, Aaron D., et al.
Publicado: (2022)

Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson’s disease
por: Thome, Aaron D., et al.
Publicado: (2021)

Tregs Attenuate Peripheral Oxidative Stress and Acute Phase Proteins in ALS
por: Beers, David R., et al.
Publicado: (2022)

Restoring regulatory T-cell dysfunction in Alzheimer’s disease through ex vivo expansion
por: Faridar, Alireza, et al.
Publicado: (2020)

Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer’s disease
por: Faridar, Alireza, et al.
Publicado: (2022)

Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival
por: Henkel, Jenny S, et al.
Publicado: (2013)

Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival
por: Henkel, Jenny S, et al.
Publicado: (2013)

Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis
por: Beers, David R., et al.
Publicado: (2011)

Immunosuppressive Functions of M2 Macrophages Derived from iPSCs of Patients with ALS and Healthy Controls
por: Zhao, Weihua, et al.
Publicado: (2020)

Serum programmed cell death proteins in amyotrophic lateral sclerosis
por: Beers, David R., et al.
Publicado: (2021)

Functional alterations of myeloid cells during the course of Alzheimer’s disease
por: Thome, Aaron D., et al.
Publicado: (2018)

Elevated acute phase proteins reflect peripheral inflammation and disease severity in patients with amyotrophic lateral sclerosis
por: Beers, David R., et al.
Publicado: (2020)

Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study Design
por: Berry, James, et al.
Publicado: (2021)

Race/ethnicity, socioeconomic status, and ALS mortality in the United States
por: Roberts, Andrea L., et al.
Publicado: (2016)

Randomized phase 2 trial of NP001–a novel immune regulator: Safety and early efficacy in ALS
por: Miller, Robert G., et al.
Publicado: (2015)

Job-related formaldehyde exposure and ALS mortality in the USA
por: Roberts, Andrea L, et al.
Publicado: (2016)

The Microglial-Motoneuron dialogue in ALS
por: APPEL, S.H., et al.
Publicado: (2011)

Profound Muscle Weakness and Pain after One Dose of Actonel
por: Badayan, Irina, et al.
Publicado: (2009)

Ex vivo expanded autologous polyclonal regulatory T cells suppress inhibitor formation in hemophilia
por: Sarkar, Debalina, et al.
Publicado: (2014)

Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS
por: Benatar, Michael, et al.
Publicado: (2018)

How common are ALS plateaus and reversals?
por: Bedlack, Richard S., et al.
Publicado: (2016)

Bortezomib Treatment to Potentiate the Anti-tumor Immunity of Ex-vivo Expanded Adoptively Infused Autologous Natural Killer Cells
por: Lundqvist, Andreas, et al.
Publicado: (2011)

Military Service and Amyotrophic Lateral Sclerosis in a Population-based Cohort
por: Weisskopf, Marc G., et al.
Publicado: (2015)

Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells
por: Ra, Jeong Chan, et al.
Publicado: (2011)

Intravenous Infusion of Autoserum-Expanded Autologous Mesenchymal Stem Cells in Patients With Chronic Brain Injury: Protocol for a Phase 2 Trial
por: Oka, Shinichi, et al.
Publicado: (2022)

Lymphocyte transformation induced by autologous cells. V. generation of immunologic memory and specificity during the autologous mixed lymphocyte reaction
por: Weksler, ME, et al.
Publicado: (1977)

Evaluation of allogeneic and autologous membrane-bound IL-21–expanded NK cells for chronic lymphocytic leukemia therapy
por: Yano, Max, et al.
Publicado: (2022)

Lymphocyte transformation induced by autologous cells. IV. Human T- lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes
Publicado: (1976)

Nutritional counseling with or without mobile health technology: a randomized open-label standard-of-care-controlled trial in ALS
por: Wills, Anne Marie, et al.
Publicado: (2019)

Infused autograft lymphocyte-to-monocyte ratio and survival in T-cell lymphoma post-autologous peripheral blood hematopoietic stem cell transplantation
por: Porrata, Luis F., et al.
Publicado: (2015)

Myeloablative treatment supported by autologous stem cell infusion with neuroblastoma.
por: Ryu, Kyung Ha, et al.
Publicado: (2003)

Infusion of Autologous Retrodifferentiated Stem Cells into Patients with Beta-Thalassemia
por: Abuljadayel, Ilham Saleh, et al.
Publicado: (2006)

Serum Ferritin and Metal Levels as Risk Factors for Amyotrophic Lateral Sclerosis
por: Qureshi, Muddasir, et al.
Publicado: (2008)

Excess Circulating Alternatively Activated Myeloid (M2) Cells Accelerate ALS Progression While Inhibiting Experimental Autoimmune Encephalomyelitis
por: Vaknin, Ilan, et al.
Publicado: (2011)

Autologous stimulation of human lymphocyte subpopulation
Publicado: (1975)

Phase I Clinical Trial Using Autologous Ex Vivo Expanded NK Cells and Cytotoxic T Lymphocytes for Cancer Treatment in Vietnam
por: Liem, Nguyen Thanh, et al.
Publicado: (2019)

NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results
por: Berry, James D., et al.
Publicado: (2019)

Preclinical rodent toxicity studies for long term use of ceftriaxone
por: Ratti, Elena, et al.
Publicado: (2015)

Developing multidisciplinary clinics for neuromuscular care and research
por: Paganoni, Sabrina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9kp8dbe4norqtoda9i5a40d23i